Evidence map›Paper›PMID 41593489›Full record

ReviewDrug delivery2026

Microalgae as novel drug-delivery system for biomedical field.

Yueyou Dai, Dandan Guo, Aifang Li, Wei Chen, Yi Yang, Shuxuan Li, Lianhe Yang, Shuying Feng

Abstract readReview
In one paragraph

Review in Drug delivery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Bioactive Compounds of Ginger (Antibiotics (Basel, Switzerland) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yueyou DaiMedical College, Henan University of Chinese Medicine, Zhengzhou, People's Republic of China.
Dandan GuoMedical College, Henan University of Chinese Medicine, Zhengzhou, People's Republic of China.
Aifang LiMedical College, Henan University of Chinese Medicine, Zhengzhou, People's Republic of China.
Wei ChenMedical College, Henan University of Chinese Medicine, Zhengzhou, People's Republic of China.
Yi YangMedical College, Henan University of Chinese Medicine, Zhengzhou, People's Republic of China.
Shuxuan LiMedical College, Henan University of Chinese Medicine, Zhengzhou, People's Republic of China.
Lianhe YangMedical College, Henan University of Chinese Medicine, Zhengzhou, People's Republic of China.
Shuying FengMedical College, Henan University of Chinese Medicine, Zhengzhou, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, increasing attention is being paid to the extraction and utilization of materials with special biological activities in nature or for medical applications. Owing to their unique biological characteristics and diverse application potential, microalgae are among the most promising materials in the field of biomedicine. Because of their diverse morphology and readily functionalizable surface, they can efficiently carry drugs and achieve targeted drug release. This can avoid major challenges of other methods related to toxicity, biocompatibility, and immunogenicity, which is important for the treatment of various diseases, particularly those related to hypoxia. Despite the distinct advantages of microalgae over other biomaterials, several challenges persist in their practical application. Herein, we comprehensively describe the current state of research on the microalgae drug-delivery system (MDDS). In particular, we explore various microalgae-based strategies and methods to improve the load capacity and stability of DDS, and to achieve target positioning and tracking. With further research on microalgae, their application prospects in DDSs will broaden. In the future, researchers will continue to explore the features and advantages of microalgae; develop more efficient, safe, and accurate DDSs; and provide more options for clinical treatments. Continued progress in microalgal cultivation technology and reduction in large-scale production costs will expand the clinical applications of MDDSs.

Indexed as

Drug Delivery SystemsMicroalgaeAnimalsDrug CarriersDrug LiberationHumansDrug Carriersdelivery systemdisease treatmentMicroalgaesafety evaluationtargeted therapeutic

Identifiers

PMID41593489
PMCPMC12854229

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.